E
Lyell Immunopharma, Inc. LYEL
$10.64 -$0.33-3.01% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -331.40M -334.52M -342.99M -203.99M -210.26M
Total Depreciation and Amortization 16.28M 18.05M 19.63M 19.66M 20.09M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 152.99M 150.80M 164.09M 29.97M 31.79M
Change in Net Operating Assets -9.36M -9.44M -3.12M -1.43M -43.00K
Cash from Operations -171.48M -175.12M -162.39M -155.79M -158.43M
Capital Expenditure -517.00K -680.00K -464.00K -445.00K -581.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -31.35M -31.35M -31.35M -- --
Divestitures -- -- -- -- --
Other Investing Activities 169.40M 201.92M 154.23M -31.33M 66.56M
Cash from Investing 137.54M 169.90M 122.42M -31.77M 65.98M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 621.00K 1.30M 1.40M 1.85M 1.92M
Repurchase of Common Stock 0.00 0.00 -76.00K -199.00K -414.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 1.00K -- -- --
Cash from Financing 621.00K 1.30M 1.33M 1.65M 1.51M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -33.32M -3.92M -38.64M -185.91M -90.94M